The Journal of Pediatrics
Volume 149, Issue 1, Supplement , Pages S34-S38, July 2006

Ethical issues arising from the participation of children in genetic research

  • Wylie Burke, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Dr Wylie Burke, Department of Medical History and Ethics, University of Washington, Box 357120, 1959 NE Pacific, Room A204, Seattle, WA 98195-7120.
  • ,
  • Douglas S. Diekema, MD, MPH

From the Department of Medical History and Ethics, and the Department of Pediatrics, University of Washington; and the Children’s Hospital and Regional Medical Center, Seattle, Washington.

With new tools derived from the Human Genome Project, genetic research is expanding from the study of rare, single gene disorders to the evaluation of genetic contributors to common, complex diseases. Many genetic studies include pediatric participants. The ethical concerns related to pediatric participation in genetic research derive from the study designs commonly employed in gene discovery and from the power accorded to genetic prediction in our society. In both family-based studies and large studies combining genetic and other health-related data, special attention should be placed on recruitment procedures, informed consent, and confidentiality protections. If data repositories are created for long-term use, we recommend re-consent of pediatric participants when they reach adulthood. In addition, the potential for disclosure of individual results should be considered as part of the institutional review of genetic studies, taking into account the validity of research data and the potential that such data could be used in health care. The potential for genetic results to pose harms of personal and group stigma is also a consideration. Because genetic information is often accorded special power in our society, careful attention should be paid to how genetic information is collected and used in research involving pediatric participants.

Abbreviations:  NBAC, National Bioethics Advisory Commission , TPMT, thiopurine methyltransferase

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by the University of Washington NHGRI sponsored Center for Genomics and Healthcare Equality Grant #: NHGRI P50HG03374.

PII: S0022-3476(06)00375-1

doi:10.1016/j.jpeds.2006.04.049

The Journal of Pediatrics
Volume 149, Issue 1, Supplement , Pages S34-S38, July 2006